Connect Sign In
LabMind podcasts
The 38th Annual Park City Anatomic Pathology Update offers an opportunity for community pathologists to connect with experts and engage in discussion of practical topics and updates. |
November 27, 2024 |
Why Community Pathologists Attend the Park City Anatomic Pathology Update Year After Year ARUP Laboratories will host the Park City Anatomic Pathology Update from February 9–13, 2025. The event will feature topics on gastrointestinal (GI), pancreatic, and hepatobiliary pathology. |
Presentations by ARUP medical directors and scientists at AMP 2024 included timely topics in molecular pathology such as automated DNA extraction. Melanie Mallory, MS, pictured above, a lead bioinformatics scientist at ARUP, presented a poster related to the prediction of viral loads for cytomegalovirus. |
November 26, 2024 |
ARUP Research Highlighted at the Association for Molecular Pathology 2024 Annual Meeting and Expo ARUP medical directors and scientists presented key molecular pathology advancements at AMP 2024 on topics such as viral load prediction, automated DNA extraction, and parasite detection. |
|
November 19, 2024 |
A New Edition of Magnify Is Available and Focuses on the FDA’s Rule To Regulate Lab-Developed Tests This edition features interviews with company leaders describing ARUP’s approaches to comply with the FDA’s rule and a video about how ARUP helped a family on a rare disease diagnostic journey. |
Michelle Tarver, MD, PhD, director of the FDA’s Center for Devices and Radiological Health (CDRH), and Jeff Shuren, MD, JD, CDRH director emeritus, appeared virtually at the Utah Life Sciences Summit. |
November 18, 2024 | FDA leaders answered questions on artificial intelligence (AI), international regulations, and representation in clinical trials during the Utah Life Sciences Summit. |
Ryan Nelson, PharmD, medical director of Precision Medicine at ARUP, was presented with a Double Helix Award by the American Society of Pharmacovigilance (ASP). |
November 15, 2024 |
ARUP Medical Director Ryan Nelson, PharmD, Receives a STRIPE Double Helix Award Ryan Nelson, PharmD, received a Double Helix Award for his work on MetaCensus during the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Annual Meeting and Consensus Workshop. |
Laboratory tests, including those for fluid biomarkers, play a critical role in diagnosing and treating Alzheimer's disease. |
November 6, 2024 |
ARUP Consult Includes Updated Information on Biomarker Testing for Alzheimer’s Disease Diagnosis Laboratory tests, including those for fluid biomarkers, may be used to diagnose Alzheimer's disease. ARUP Consult details using such tests to help clinicians order the right test at the right time. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat